Public Joint-Stock Company PROTEK Logo

Public Joint-Stock Company PROTEK

PRTK.ME

(1.2)
Stock Price

100 RUB

2.3% ROA

8.57% ROE

14.8x PER

Market Cap.

44.197.797.804 RUB

63.21% DER

0% Yield

1.31% NPM

Public Joint-Stock Company PROTEK Stock Analysis

Public Joint-Stock Company PROTEK Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Public Joint-Stock Company PROTEK Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE in an average range (8.57%) suggests satisfactory profitability and decent utilization of shareholders' equity.

2 ROA

The stock's ROA (2.3%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

3 PBV

The stock's PBV ratio (1.24x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

4 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

5 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (14.289) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

6 DER

The company has a high debt to equity ratio (288%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

9 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Public Joint-Stock Company PROTEK Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Public Joint-Stock Company PROTEK Technical Stock Analysis
# Analysis Recommendation

Public Joint-Stock Company PROTEK Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Public Joint-Stock Company PROTEK Revenue
Year Revenue Growth
2007 63.264.634.000
2008 77.514.245.000 18.38%
2009 91.580.958.000 15.36%
2010 99.840.831.000 8.27%
2011 107.052.687.000 6.74%
2012 125.502.215.000 14.7%
2013 139.310.565.000 9.91%
2014 156.948.198.000 11.24%
2015 195.308.866.000 19.64%
2016 241.481.755.000 19.12%
2017 258.454.771.000 6.57%
2018 251.733.446.000 -2.67%
2019 265.647.338.000 5.24%
2020 534.800.000.000 50.33%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Public Joint-Stock Company PROTEK Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 62.486.000 100%
2014 85.686.000 27.08%
2015 69.350.000 -23.56%
2016 146.379.000 52.62%
2017 127.823.000 -14.52%
2018 78.882.000 -62.04%
2019 109.494.000 27.96%
2020 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Public Joint-Stock Company PROTEK General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 3.419.293.000
2008 3.496.618.000 2.21%
2009 3.965.793.000 11.83%
2010 3.739.568.000 -6.05%
2011 3.880.909.000 3.64%
2012 1.178.590.000 -229.28%
2013 1.443.214.000 18.34%
2014 1.047.229.000 -37.81%
2015 916.534.000 -14.26%
2016 1.035.318.000 11.47%
2017 1.161.850.000 10.89%
2018 1.221.106.000 4.85%
2019 1.219.319.000 -0.15%
2020 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Public Joint-Stock Company PROTEK EBITDA
Year EBITDA Growth
2007 2.487.805.000
2008 2.356.994.000 -5.55%
2009 5.746.729.000 58.99%
2010 2.499.477.000 -129.92%
2011 3.070.343.000 18.59%
2012 4.474.642.000 31.38%
2013 4.568.809.000 2.06%
2014 6.587.897.000 30.65%
2015 13.023.009.000 49.41%
2016 8.821.508.000 -47.63%
2017 9.425.734.000 6.41%
2018 10.275.040.000 8.27%
2019 12.968.194.000 20.77%
2020 37.004.000.000 64.95%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Public Joint-Stock Company PROTEK Gross Profit
Year Gross Profit Growth
2007 10.604.037.000
2008 12.873.092.000 17.63%
2009 15.440.833.000 16.63%
2010 12.807.294.000 -20.56%
2011 13.968.273.000 8.31%
2012 15.468.810.000 9.7%
2013 17.544.364.000 11.83%
2014 19.469.244.000 9.89%
2015 26.745.328.000 27.21%
2016 29.428.232.000 9.12%
2017 31.390.978.000 6.25%
2018 34.262.677.000 8.38%
2019 36.945.741.000 7.26%
2020 73.528.000.000 49.75%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Public Joint-Stock Company PROTEK Net Profit
Year Net Profit Growth
2007 549.330.000
2008 418.458.000 -31.27%
2009 3.262.017.000 87.17%
2010 922.196.000 -253.72%
2011 1.846.710.000 50.06%
2012 2.773.521.000 33.42%
2013 1.876.874.000 -47.77%
2014 4.721.768.000 60.25%
2015 10.853.529.000 56.5%
2016 5.922.035.000 -83.27%
2017 5.646.201.000 -4.89%
2018 6.184.864.000 8.71%
2019 3.480.814.000 -77.68%
2020 16.028.000.000 78.28%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Public Joint-Stock Company PROTEK Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 1
2008 1 0%
2009 7 85.71%
2010 2 -600%
2011 4 66.67%
2012 5 40%
2013 4 -66.67%
2014 9 66.67%
2015 22 57.14%
2016 12 -90.91%
2017 11 -10%
2018 12 9.09%
2019 7 -83.33%
2020 33 81.82%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Public Joint-Stock Company PROTEK Free Cashflow
Year Free Cashflow Growth
2007 354.147.000
2008 2.625.604.000 86.51%
2009 5.176.169.000 49.28%
2010 -173.511.000 3083.19%
2011 775.771.000 122.37%
2012 4.356.322.000 82.19%
2013 783.477.000 -456.02%
2014 2.340.281.000 66.52%
2015 11.210.398.000 79.12%
2016 3.905.066.000 -187.07%
2017 491.072.000 -695.21%
2018 23.661.489.000 97.92%
2019 6.262.101.000 -277.85%
2020 3.577.000.000 -75.07%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Public Joint-Stock Company PROTEK Operating Cashflow
Year Operating Cashflow Growth
2007 1.683.333.000
2008 3.092.714.000 45.57%
2009 5.712.354.000 45.86%
2010 706.507.000 -708.53%
2011 1.693.478.000 58.28%
2012 4.834.398.000 64.97%
2013 1.496.495.000 -223.05%
2014 3.508.029.000 57.34%
2015 13.101.566.000 73.22%
2016 9.049.462.000 -44.78%
2017 4.505.863.000 -100.84%
2018 27.036.028.000 83.33%
2019 11.919.790.000 -126.82%
2020 5.105.000.000 -133.49%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Public Joint-Stock Company PROTEK Capital Expenditure
Year Capital Expenditure Growth
2007 1.329.186.000
2008 467.110.000 -184.56%
2009 536.185.000 12.88%
2010 880.018.000 39.07%
2011 917.707.000 4.11%
2012 478.076.000 -91.96%
2013 713.018.000 32.95%
2014 1.167.748.000 38.94%
2015 1.891.168.000 38.25%
2016 5.144.396.000 63.24%
2017 4.014.791.000 -28.14%
2018 3.374.539.000 -18.97%
2019 5.657.689.000 40.35%
2020 1.528.000.000 -270.27%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Public Joint-Stock Company PROTEK Equity
Year Equity Growth
2007 9.849.075.000
2008 10.226.318.000 3.69%
2009 12.766.567.000 19.9%
2010 19.345.981.000 34.01%
2011 21.211.710.000 8.8%
2012 23.057.021.000 8%
2013 24.142.782.000 4.5%
2014 24.907.445.000 3.07%
2015 34.529.585.000 27.87%
2016 31.057.490.000 -11.18%
2017 33.774.372.000 8.04%
2018 39.940.478.000 15.44%
2019 42.118.170.000 5.17%
2020 38.998.405.000 -8%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Public Joint-Stock Company PROTEK Assets
Year Assets Growth
2007 42.428.101.000
2008 44.793.578.000 5.28%
2009 45.440.987.000 1.42%
2010 47.653.616.000 4.64%
2011 55.067.171.000 13.46%
2012 62.952.408.000 12.53%
2013 69.326.864.000 9.19%
2014 75.604.482.000 8.3%
2015 107.938.547.000 29.96%
2016 120.711.203.000 10.58%
2017 135.580.097.000 10.97%
2018 132.063.948.000 -2.66%
2019 162.191.680.000 18.58%
2020 148.758.862.000 -9.03%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Public Joint-Stock Company PROTEK Liabilities
Year Liabilities Growth
2007 32.579.026.000
2008 34.567.260.000 5.75%
2009 32.674.420.000 -5.79%
2010 28.307.635.000 -15.43%
2011 33.855.461.000 16.39%
2012 39.895.387.000 15.14%
2013 45.184.082.000 11.7%
2014 50.697.037.000 10.87%
2015 73.408.962.000 30.94%
2016 89.653.713.000 18.12%
2017 101.805.725.000 11.94%
2018 92.123.470.000 -10.51%
2019 120.073.510.000 23.28%
2020 109.760.457.000 -9.4%

Public Joint-Stock Company PROTEK Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
513.43
Net Income per Share
6.73
Price to Earning Ratio
14.8x
Price To Sales Ratio
0.17x
POCF Ratio
4.32
PFCF Ratio
7.06
Price to Book Ratio
1.24
EV to Sales
0.24
EV Over EBITDA
4.94
EV to Operating CashFlow
5.38
EV to FreeCashFlow
10.24
Earnings Yield
0.07
FreeCashFlow Yield
0.14
Market Cap
44 Bil.
Enterprise Value
64 Bil.
Graham Number
110.45
Graham NetNet
-105

Income Statement Metrics

Net Income per Share
6.73
Income Quality
3.24
ROE
0.09
Return On Assets
0.02
Return On Capital Employed
0.12
Net Income per EBT
0.71
EBT Per Ebit
0.64
Ebit per Revenue
0.03
Effective Tax Rate
0.25

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.14
Operating Profit Margin
0.03
Pretax Profit Margin
0.02
Net Profit Margin
0.01

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
23.04
Free CashFlow per Share
12.1
Capex to Operating CashFlow
-0.47
Capex to Revenue
-0.02
Capex to Depreciation
-1.11
Return on Invested Capital
0.08
Return on Tangible Assets
0.02
Days Sales Outstanding
53.71
Days Payables Outstanding
139.62
Days of Inventory on Hand
89.97
Receivables Turnover
6.8
Payables Turnover
2.61
Inventory Turnover
4.06
Capex per Share
-10.93

Balance Sheet

Cash per Share
15,94
Book Value per Share
80,59
Tangible Book Value per Share
60.83
Shareholders Equity per Share
80.59
Interest Debt per Share
56.69
Debt to Equity
0.63
Debt to Assets
0.16
Net Debt to EBITDA
1.54
Current Ratio
1.06
Tangible Asset Value
31 Bil.
Net Current Asset Value
-16 Bil.
Invested Capital
0.63
Working Capital
6 Bil.
Intangibles to Total Assets
0.07
Average Receivables
38 Bil.
Average Payables
85 Bil.
Average Inventory
53274686000
Debt to Market Cap
0.6

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Public Joint-Stock Company PROTEK Dividends
Year Dividends Growth
2012 0
2013 7 100%
2014 2 -600%
2016 24 95.65%
2017 6 -360%

Public Joint-Stock Company PROTEK Profile

About Public Joint-Stock Company PROTEK

PROTEK is involved in the distribution and retail sales of pharmaceuticals, health and beauty products and also manufacturing of pharmaceuticals in Russia. The company has Distribution, Retail, and Production segments. The firm only operates in the Russian Federation.

CEO
Employee
0
Address

,

Public Joint-Stock Company PROTEK Executives & BODs

Public Joint-Stock Company PROTEK Executives & BODs
# Name Age

Public Joint-Stock Company PROTEK Competitors